Myoclonic dystonia.
Pueschel SM, Friedman JH, Shetty T.
Childs Nerv Syst. 1992 Mar;8(2):61-6. doi: 10.1007/BF00298440.
Myoclonic dystonia.
Obeso JA, Rothwell JC, Lang AE, Marsden CD.
Neurology. 1983 Jul;33(7):825-30. doi: 10.1212/wnl.33.7.825.
Myoclonus-dystonia syndrome.
Nardocci N.
Handb Clin Neurol. 2011;100:563-75. doi: 10.1016/B978-0-444-52014-2.00041-0.
Myoclonic dystonia (DYT11) responsive to lacosamide: a case report.
Salari M, Asadi S, Etemadifar M, Rezaee M.
Acta Neurol Belg. 2022 Dec;122(6):1631-1632. doi: 10.1007/s13760-021-01756-5. Epub 2021 Jul 17.
[Myoclonic dystonia].
Cassim F.
Rev Neurol (Paris). 2003 Oct;159(10 Pt 1):892-9.
Essential myoclonus and myoclonic dystonia.
Quinn NP.
Mov Disord. 1996 Mar;11(2):119-24. doi: 10.1002/mds.870110202.
Correction to: Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I, Serranová T, Prouteau C, Colin E, Ziegler A, Winkelmann J, Jech R, Zech M.
Neurogenetics. 2022 Jan;23(1):77. doi: 10.1007/s10048-021-00641-w.
Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I, Serranová T, Prouteau C, Colin E, Ziegler A, Winkelmann J, Jech R, Zech M.
Neurogenetics. 2021 May;22(2):137-141. doi: 10.1007/s10048-021-00637-6. Epub 2021 Mar 6.
ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.
Cazurro-Gutiérrez A, Marcé-Grau A, Correa-Vela M, Salazar A, Vanegas MI, Macaya A, Bayés À, Pérez-Dueñas B.
Mol Neurobiol. 2021 Aug;58(8):3938-3952. doi: 10.1007/s12035-021-02391-0. Epub 2021 Apr 22.
Myoclonic Dystonia: A Common Phenomenology in the Pleomorphic Movements of Angelman Syndrome.
Carson RP, Riordan H, Short B, Davis T, Fang J, Giritharan A, Isaacs DA, Blackburn J, Aravamuthan B.
Mov Disord Clin Pract. 2025 May 2. doi: 10.1002/mdc3.70106. Online ahead of print.
